Soleno Therapeutics(SLNO) - 2021 Q4 - Annual Report

| UNITED STATES | | --- | | SECURITIES AND EXCHANGE COMMISSION | | Washington, D.C. 20549 | | FORM 10-K | | (Mark One) | | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☒ | | For the fiscal year ended: December 31, 2021 | | ☐ | | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | For the transition period from to . | | Commission File No.: 001-36593 | | Soleno Therapeutics, Inc. | | (Exact name of Registrant as specified in its ...